Switching from dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor to dual pathway inhibition with aspirin plus vascular-dose rivaroxaban.
Sign Up to like & getrecommendations! Published in 2023 at "Thrombosis and haemostasis"
DOI: 10.1055/a-2098-6639
Abstract: BACKGROUND To date, there is no data on switching to dual pathway inhibition (DPI) patients who have completed a guideline-recommended dual antiplatelet therapy (DAPT) regimen. OBJECTIVES To assess the feasibility of switching from DAPT to… read more here.
Keywords: switching dual; inhibition; dual pathway; aspirin plus ... See more keywords
Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000010123
Abstract: Background: The standardization for the clinical use of drug therapy for cerebral infarction (CI) has not yet determined in some aspects. In this paper, we discussed the efficacies of different drug therapies (aspirin, aspirin plus… read more here.
Keywords: aspirin plus; cerebral infarction; rate; drug therapies ... See more keywords
Combination of aspirin plus macrolides in patients with severe community-acquired pneumonia: a hypothesis-generating study
Sign Up to like & getrecommendations! Published in 2018 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.01556-18
Abstract: Objectives. While the inflammatory response to severe pneumonia is paramount in reining in and resolving the infection, the excessive inflammation can lead to deleterious effects. We theorized that patients with severe community-acquired pneumonia (CAP), treated… read more here.
Keywords: combination aspirin; patients severe; aspirin plus; severe community ... See more keywords
Abstract 159: Acute Aspirin Plus Cilostazol Dual Therapy for Non-cardioembolic Stroke Study (ADS)
Sign Up to like & getrecommendations! Published in 2018 at "Stroke"
DOI: 10.1161/str.49.suppl_1.159
Abstract: Hypothesis: The aim of the present study was to investigate the efficacy and safety of antiplatelet (aspirin plus cilostazol) dual therapy for non-cardioembolic stroke patients within 48 h of sympt... read more here.
Keywords: cilostazol dual; aspirin plus; dual therapy; plus cilostazol ... See more keywords
Clinical Study of Aspirin and Zileuton on Biomarkers of Tobacco-Related Carcinogenesis in Current Smokers
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14122893
Abstract: Simple Summary Aspirin and related drugs with anti-inflammatory effects have lung cancer prevention effects in laboratory studies and through their use in populations at risk for lung cancer. We studied aspirin plus zileuton compared to… read more here.
Keywords: lung cancer; lung; aspirin plus; gene ... See more keywords
Aspirin plus clopidogrel was not linked to risk for cancer compared with aspirin alone or no antiplatelets
Sign Up to like & getrecommendations! Published in 2017 at "Annals of Internal Medicine"
DOI: 10.7326/acpjc-2017-167-2-010
Abstract: Question What is the association between treatment with aspirin plus clopidogrel compared with aspirin alone or no antiplatelet use and risk for cancer? Methods Setting Sharon-Shomron district, Israel. Patients 184781 adults 50 years of age… read more here.
Keywords: risk; clopidogrel; aspirin plus; aspirin alone ... See more keywords